Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, is a nonspecific chronic inflammation of the gastrointestinal tract. Despite recent advances in therapeutics and newer management strategies, IBD largely remains untreatable. Helminth therapy is a promising alternative therapeutic for IBD that has gained some attention in the last two decades. Helminths have immunomodulatory effects and can alter the gut microbiota. The immunomodulatory effects include a strong Th2 immune response, T-regulatory cell response, and the production of regulatory cytokines. Although concrete evidence regarding the efficacy of helminth therapy in IBD is lacking, clinical studies and studies done in animal models have shown some promise. Most clinical studies have shown that helminth therapy is safe and easily tolerable. Extensive work has been done on the whipworm Trichuris, but other helminths, including Schistosoma, Trichinella, Heligmosomoides, and Ancylostoma, have also been explored for pre-clinical and animal studies. This review article summarizes the potential of helminth therapy as an alternative therapeutic or an adjuvant to the existing therapeutic procedures for IBD treatment.
Citations
Citations to this article as recorded by
Recombinant Macrophage Migration Inhibitory Factor Derived from Trichinella spiralis Suppresses Obesity by Reducing Body Fat and Inflammation Seo Yeong Choi, Mi-Kyung Park, Yu Jin Jeong, Dong Gyu Han, Chaeeun Jin, Chang Woo Han, Se Bok Jang, Shin Ae Kang, Hak Sun Yu International Journal of Molecular Sciences.2026; 27(2): 887. CrossRef
Anti-Inflammatory Effect of Excretion-Secretion Products of Clinostomum marginatum (Digenea: Clinostomidae) and Its Effect over the Viability and Antioxidative Activity of a Mix of Lactobacillus and/or Bifidobacterium María Angélica Gutiérrez-Nava, Raquel González-Vázquez, Miguel Ángel Mosqueda-Cabrera, Daniela Reyna-González, Felipe Mendoza-Pérez, Eduardo Zúñiga-León, Leovigildo Mateos-Sánchez, Pedro A. Reyes-Castillo, Rosa González-Vázquez, María Guadalupe Córdova-Es Microorganisms.2026; 14(2): 354. CrossRef
Gut pathogen Clostridium symbiosum rewires macrophage succinylation to drive enteric neuron loss in inflammatory bowel disease Ying Zhao, Lijun Ning, Yuqing Yan, Jinmei Ding, Bin Yu, Pengjie Yang, Nan Shen, Baoqin Xuan, Zhenyu Wang, Yue Zhang, Yi-Lu Zhou, Yuqi Shao, Yi Jiang, Yanru Ma, Xiaoqiang Zhu, Xiaowen Huang, Muni Hu, Chaoqin Shen, Danfeng Sun, Jianyong Sun, Ruogu Li, Sheng Cell Host & Microbe.2026; 34(4): 620. CrossRef
The TPx Protein of Cysticercus cellulosae Promotes an IL-10–Producing Regulatory B Cell Phenotype in Human B Lymphoblastoid Cells via the cAMP/CREB Pathway Haojun Cai, Xue Li, Haiting Xiong, Qianqian Mu, Biying Zhou Cells.2026; 15(16): 1429. CrossRef
In vivo reduction of Treg expansion in rodent helminth–malaria coinfection Luc Bourbon, Aloïs Dusuel, Nicolas Pernet, Mickaël Rialland, Benjamin Roche, Bruno Faivre, Gabriele Sorci Parasites & Vectors.2026;[Epub] CrossRef
Generation of Immune Modulating Small Metabolites—Metabokines—By Adult Schistosomes Patrick J. Skelly, Akram A. Da’dara Pathogens.2025; 14(6): 526. CrossRef
An experimental study of the dual modulation of the colchicine-induced rat model of Alzheimer’s disease by superparamagnetic iron oxide nanoparticles (SPIONs) and the soluble product of Dipylidium caninum adult worm Amal M. Elsharkawy, Faika Hassanein, Samia S. Abouelkheir, Inas M. Masoud, Wael Felefel, Inas E. Darwish, Abdelfattah Selim PLOS One.2025; 20(6): e0324191. CrossRef
The Impact of Helminths on Colorectal Cancer: From Infections to the Isolation of Biotherapeutics Cuauhtémoc Ángel Sánchez-Barrera, Karen V. Fernandez-Muñoz, Mónica G. Mendoza-Rodríguez, María T. Ortiz-Melo, Jazmín A. Carrillo-Pérez, Miriam Rodríguez-Sosa, Luis I. Terrazas Pathogens.2025; 14(9): 949. CrossRef
Advancements in therapeutic strategies and drug development for inflammatory bowel diseases Yu Zhou, Fang Shen Exploration of Immunology.2025;[Epub] CrossRef
Inflammatory bowel disease (IBD) is a multifactorial disease, which is thought to be an interplay between genetic, environment, microbiota, and immune-mediated factors. Dysbiosis in the gut microbial composition, caused by antibiotics and diet, is closely related to the initiation and progression of IBD. Differences in gut microbiota composition between IBD patients and healthy individuals have been found, with reduced biodiversity of commensal microbes and colonization of opportunistic microbes in IBD patients. Gut microbiota can, therefore, potentially be used for diagnosing and prognosticating IBD, and predicting its treatment response. Currently, there are no curative therapies for IBD. Microbiota-based interventions, including probiotics, prebiotics, synbiotics, and fecal microbiota transplantation, have been recognized as promising therapeutic strategies. Clinical studies and studies done in animal models have provided sufficient evidence that microbiota-based interventions may improve inflammation, the remission rate, and microscopic aspects of IBD. Further studies are required to better understand the mechanisms of action of such interventions. This will help in enhancing their effectiveness and developing personalized therapies. The present review summarizes the relationship between gut microbiota and IBD immunopathogenesis. It also discusses the use of gut microbiota as a noninvasive biomarker and potential therapeutic option.
Citations
Citations to this article as recorded by
Therapeutic Potential and Functional Mechanisms of Probiotics as Prospective anti-inflammatory Agents Ridhika Bangotra, Bisma Habib, Mohd. Younis, Gurleen Kour, Nisha Kapoor, Ritu Mahajan, Zabeer Ahmed, Bijender Kumar Bajaj Probiotics and Antimicrobial Proteins.2026; 18(4): 5289. CrossRef
Effects of stoma discharge reinfusion on low anterior resection syndrome and the gut microbiota following sphincter-preserving surgery for middle and low rectal cancer: a randomized clinical trial Shiwei Zhang, Liang He, Luyao Zhang, Jianan Sun, Yanjun Wang, Meiling Wang, Yinquan Zhao, Xuan Sun, Yang Gong, Zhong Li, Yuchen Guo, Quan Wang Updates in Surgery.2026; 78(2): 619. CrossRef
A Comprehensive Narrative Review of Potential Gastrointestinal Adverse Effects From Micro(nano) Plastic Exposure Priyata Dutta, Sana Rabeeah, Alejandra Vargas, Edward C. Oldfield, David A. Johnson Clinical Gastroenterology and Hepatology.2026; 24(4): 881. CrossRef
Oxidized Wheat Germ Protein Induces Oxidative Stress and Inflammation by Altering Gut Microbiota in Mice Yiming Li, Wenliang Zhao, Kun Zhan, Luanfeng Wang, Fang Wang, Haizhao Song, Fei Zeng, Zebin Weng, Xinchun Shen ACS Food Science & Technology.2026; 6(1): 37. CrossRef
Cobalamin-mediated protection of Faecalibacterium duncaniae against oxidative stress: Insights from proteomic and membrane fatty acid profiles Maria Alejandra de Angel Fontalvo, Simon Ménard, Rime Chebbo, Jasmina Vidic, Alban Amoros, Christine Péchoux, Lydie Oliveira Correia, Sébastien Dupont, Florence Dubois-Brissonnet, Laurent Beney, Bonastre Oliete, Jean-Marc Chatel, Sandrine Auger Microbiological Research.2026; 306: 128455. CrossRef
Role of miR-338-3p and miR-378a-3p as regulators in Crohn's disease pathogenesis: Potential therapeutic implications in inflammatory bowel disease Ki-Uk Kim, Jung Min Moon, Eunsu Lim, Kang-Bin Dan, Jeongkuk Seo, Kyuwon Kim, Seung Yong Shin, Hyeyoung Min, Chang Hwan Choi Life Sciences.2026; 389: 124217. CrossRef
Probiotic and prebiotic mechanisms in IBD-associated colorectal carcinogenesis: recent advances Xueru Fan, Xiaoge Wang, Yang Chao, Erping Xu Frontiers in Nutrition.2026;[Epub] CrossRef
Butyrate-Producing Bacteria as a Keystone Species of the Gut Microbiome: A Systemic Review of Dietary Impact on Gut–Brain and Host Health Jacob L. Snodgrass, Bisi T. Velayudhan International Journal of Molecular Sciences.2026; 27(3): 1289. CrossRef
Relationship between the appendix and ulcerative colitis: A new discovery Xu-Jia Wu, Reng-Yun Xiang, Pan Gong, Qian Chen, Xue-Feng Li World Journal of Gastrointestinal Endoscopy.2026;[Epub] CrossRef
Diagnostic challenges and treatment approaches for Clostridioides difficile infection in IBD patients Asghar Ali, Khalid I. AlHussaini Frontiers in Microbiology.2026;[Epub] CrossRef
The epidemiology of inflammatory bowel disease: exploring the impacts of environmental factors Jihye Park, Jae Hee Cheon The Korean Journal of Internal Medicine.2026; 41(2): 186. CrossRef
Host–microbe interaction networks revealed through gut microbiota and microRNA correlation analysis in mouse models of chronic colitis and colitis-associated cancer Jae Gon Lee, In Ho Kang, A-reum Lee, Eun Hye Oh, Chan Hyuk Park, Dong Soo Han, Chang Soo Eun Journal of Translational Medicine.2026;[Epub] CrossRef
Deciphering the mitochondria–gut microbiota axis in irritable bowel syndrome: pathogenic insights and therapeutic frontiers Lifang Zeng, Wenpeng Zhou Journal of Translational Medicine.2026;[Epub] CrossRef
Gut Microbiota Alterations and Dysbiosis Patterns in Pediatric Inflammatory Bowel Disease: Clinical Correlations and Therapeutic Impact Anda-Maria Beca, Roxana Folescu, Adina Teodora Crăciun, Laura Olariu, Ileana Enatescu, Bianca Belei, Oana Belei Journal of Clinical Medicine.2026; 15(4): 1589. CrossRef
Maternal gut microbial legacy shapes intestinal health and susceptibility of offspring to colitis Ji-Min Lee, Min-Ji Kim, Hoyul Lee, Yujin Hyun, Sung-Wook Nam, Dong-Gyu Jeon, Jae-Ho Shin, Eun Soo Kim npj Biofilms and Microbiomes.2026;[Epub] CrossRef
Study on the predictive model of response of patients with inflammatory bowel disease to infliximab treatment Ru Ding, Mengdi Fan, Juanjuan Gu, Zhangning Zhou Investigación Clínica.2026; 67(1): 57. CrossRef
Тhe effect of microbiota on inflammatory processes in the intestine I. M. VASYLYEVA, N. V. YARMYSH, O. A. NAKONECHNA Experimental and Clinical Physiology and Biochemistry.2026; 104(4): 27. CrossRef
Integrated multi-omics profiling of gut microbiome and metabolome in ulcerative colitis insights from the Iranian population Seyedeh Maryam Mousavi, Mohammad Roayaei Ardakani, Hamid Galehdari, Mehran Dorostghoal iScience.2026; 29(3): 114721. CrossRef
Targeting Gut Microbiota in Drug Therapy: Targeting Health Through Restoration of Intestinal Viable Ecosystems (Thrive) - A New Frontier in Pharmacology Mehul Bhatt, Hansal Desai Research Journal of Pharmacognosy and Phytochemistry.2026; 18(2): 169. CrossRef
Dietary potassium poly-γ-glutamate alleviates inflammatory responses in LPS-stimulated macrophages and DSS-induced acute colitis Jae-Chul Choi, SuHyun Hwang, Yena Oh, Hyo Jung Ku, JiHae Choi, KyungBae Lee, KwangEun Yeo, Sanghoon Park, Seong Hwan Kim, MyungSun Cho, JungMin Bae Journal of Functional Foods.2026; 141: 107303. CrossRef
CXCL5 is associated with neutrophil-driven intestinal inflammation and IL-17-associated epithelial signaling in inflammatory bowel disease Jung Min Moon, Eunsu Lim, Hyeyoung Min, Kwang Woo Kim, Hyunsun Park, Seong-Joon Koh, Joo Sung Kim Scientific Reports.2026;[Epub] CrossRef
Astaxanthin mitigates dextran sulfate sodium-induced colitis by strengthening intestinal barrier function and suppressing oxidative stress and inflammasome activation Kwang-Youn Kim, Hado Choi, Yun-Mi Kang, Yeon-Ji Kim, Tae In Kim, Hee-Jin Eom, Hyun Woung Shin, Sang Mok Jung, Kyungho Kim Journal of Functional Foods.2026; 142: 107359. CrossRef
Gut Bacteria: A Beneficial Symbiosis or a Hidden Threat? Investigating the Dual Role of Bacteria in Gastrointestinal Diseases Fatemeh Soltani-Moghadam, Hossein Samadi Kafil, Fatemeh Yeghaneh Sefidan, Javad Nezhadi, Samira Saedi, Yalda Mohammadzadeh-Asl, Simin Sattarpour, Mohammad Ahangarzadeh Rezaee Current Microbiology.2026;[Epub] CrossRef
Specificity vs. Synergy Between Single-Strain and Multi-Strain Probiotics for Ulcerative Colitis Treatment: A Review of the Literature Muhammad Ikhmal Rosali, Dinesh Prasad V. Thanga Velu, Mohd Helmy Mokhtar, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar, Adila A. Hamid Biomedicines.2026; 14(6): 1386. CrossRef
Targeting the gut-brain axis by prebiotics and probiotics: Integrating emerging strategies in IBD management Devanshi Gupta, Muskan Kumari Gupta, Farhaque Parveen, Aparna Agarwal Human Nutrition & Metabolism.2026; 45: 200369. CrossRef
Reconstructing the intestinal microbiota ecological network based on graph neural network and contrastive learning: Predicting key microbiota regulatory targets in Crohn’s Disease Huiyi Liu Computational Biology and Chemistry.2026; 124: 109248. CrossRef
Antibiotic Class-Specific Effects on Inflammatory Bowel Disease: Microbiome Disruption, Risk, and Recovery Bhargavi Rajarathinam, Pranav V. Nair, Neeraja Murali, Ganga Lekshmi, Abitha K. Sajeev, Archa B. Pillai, Anita Thomas, Sreetha Hely, Kalyani Arun, Vidhya Prakash, Bipin G. Nair, Parvathy Venugopal, Rajaguru Aradhya International Journal of Molecular Sciences.2026; 27(14): 6502. CrossRef
A novel multi-epitope mRNA vaccine against Escherichia coli using an in silico reverse vaccinology approach Shakeela Parveen, Javeria Abbasi, Muhammad Hussain, Muhammad Farhan Khan, Muhammad Tayyab, Amina Parveen, Laiba Shafique Journal of Applied Genetics.2026;[Epub] CrossRef
Proactive therapeutic drug monitoring of infliximab leads to treatment durability in paediatric Crohn's disease: A single‐centre Australian experience Cher Wei Chuah, Jessica Eldredge, Annabel Magoffin, Edward Vincent O'Loughlin, Calvin Joomann Park, Juliana Puppi, Susan Siew, Michael Stormon, Kunal Thacker, Shoma Dutt JPGN Reports.2026;[Epub] CrossRef
Research Progress on the Treatment of Ulcerative Colitis with Puerarin 亚宁 王 Hans Journal of Medicinal Chemistry.2026; 14(03): 244. CrossRef
Adjunctive nutraceutical strategies in ulcerative colitis: From molecular pathways to clinical outcomes Carlo Caputo, Azzurra Chiara De Maio, Angela Lombardi, Rossella Sperlongano, Michele Caraglia, Domenico Cautela Biomedicine & Pharmacotherapy.2026; 203: 119855. CrossRef
A Multi‐Target Approach to Colitis: Ergothioneine Promotes Recovery by Restoring the Intestinal Barrier, Reducing Inflammation, and Remodeling the Microbiota Lin Wang, Yao Song, Yucong Wang, Zhixin Xie, Xihan Xu, Jianchun Han, Rongxu Liu Food Science & Nutrition.2026;[Epub] CrossRef
Poricoic acid A administered during DSS exposure attenuates acute colitis in mice and is accompanied by barrier-associated changes and endpoint fecal microbiota shifts Mei Wang, Kunkun Zhang, Danli Wang, Mingtao Cao, Rong Yong, Xiangqian Li, Wenyi Chen, Chengcheng Peng, Jiale Chang, Lu Fang, Feiyang Zhou, Yuyue Wan, Jingran Wang, Zhi Zhou, Lin Chen Journal of Natural Medicines.2026;[Epub] CrossRef
Long-term developmental alterations in intestinal microbiota, metabolism, and T-cell homeostasis in offspring rats following maternal tetrabromobisphenol A exposure Shuyang Huang, Chongxiang Zeng, Jiao Yang, Zenghua Qi, Yinfeng Zhou, Guoxia Zhang, Yingxin Yu Journal of Hazardous Materials.2026; 517: 143706. CrossRef
Fecal microbiota fermenting simple organic carbon substrates in vitro as microbial factories capable of distinguishing Crohn’s disease from healthy states Anna Detman-Ignatowska, Gabriele Schiro, Rafał Filip, Emilia Samborowska, Jakub Karczmarski, Sara Jarmakiewicz-Czaja, Kinga Jakubowska, Anna Williams, Nabahi Ramos Hickman, Daniel Laubitz, Anna Sikora Microbial Cell Factories.2026;[Epub] CrossRef
Enterotype-based stratification identifies clinically distinct microbial subtypes in inflammatory bowel disease Seungpyo Hong, Kwang Woo Kim, Yeram Im, Jaeyoung Jang, Dae Hee Cheon, Eun Kyoung Lee, Yoo Min Han, Jun Won Park, Hyun Jung Lee, Hyunsun Park, Seong Jin Jo, Donghyun Kim, Hyoun Woo Kang, Jong Pil Im, Eun Soo Kim, Ji Won Kim, Byeong Gwan Kim, Joo Sung Kim, Inflammatory Bowel Diseases.2026;[Epub] CrossRef
Chitosan and its derivatives: A novel approach to gut microbiota modulation and immune system enhancement Great Iruoghene Edo, Alice Njolke Mafe, Ali B.M. Ali, Patrick Othuke Akpoghelie, Emad Yousif, Jesse Innocent Apameio, Endurance Fegor Isoje, Ufuoma Augustina Igbuku, Yasal Garba, Arthur Efeoghene Athan Essaghah, Dina S. Ahmed, Huzaifa Umar, Dilber Uzun Oz International Journal of Biological Macromolecules.2025; 289: 138633. CrossRef
Advances in bio-polymer coatings for probiotic microencapsulation: chitosan and beyond for enhanced stability and controlled release Great Iruoghene Edo, Alice Njolke Mafe, Nawar. F. Razooqi, Ebuka Chukwuma Umelo, Tayser Sumer Gaaz, Endurance Fegor Isoje, Ufuoma Augustina Igbuku, Patrick Othuke Akpoghelie, Rapheal Ajiri Opiti, Arthur Efeoghene Athan Essaghah, Dina S. Ahmed, Huzaifa Uma Designed Monomers and Polymers.2025; 28(1): 1. CrossRef
Helminths in alternative therapeutics of inflammatory bowel disease Himani Pandey, Daryl W. T. Tang, Sunny H. Wong, Devi Lal Intestinal Research.2025; 23(1): 8. CrossRef
Protective effect of low-dose lactulose in dextran sulfate sodium induced ulcerative colitis model of rats Min Cui, Wei-Ming Yang, Ping Yao Scientific Reports.2025;[Epub] CrossRef
Unraveling the Role of Fusobacterium nucleatum in Colorectal Cancer: Molecular Mechanisms and Pathogenic Insights Linda Galasso, Fabrizio Termite, Irene Mignini, Giorgio Esposto, Raffaele Borriello, Federica Vitale, Alberto Nicoletti, Mattia Paratore, Maria Elena Ainora, Antonio Gasbarrini, Maria Assunta Zocco Cancers.2025; 17(3): 368. CrossRef
Lactobacillus vaginalis alleviates DSS induced colitis by regulating the gut microbiota and increasing the production of 3-indoleacrylic acid Zhuoya Wang, Tian Liu, Li Liu, Jian Xie, Furui Tang, Yimin Pi, Yuchun Zhong, Zhidong He, Wenming Zhang, Cihua Zheng Pharmacological Research.2025; 213: 107663. CrossRef
Therapeutic systems based on natural gut microbiota modulators: the latest advances in the treatment of inflammatory bowel disease Zelin Guan, Peilin Niu, Qichao Tan, Yidong Wang, Shujing Deng, Danyang Wang, Kai Dong, Jianfeng Xing, Cuiyu You Materials Advances.2025; 6(5): 1578. CrossRef
Metabolic musculoskeletal disorders in patients with inflammatory bowel disease Young Joo Yang, Seong Ran Jeon The Korean Journal of Internal Medicine.2025; 40(2): 181. CrossRef
Photobiomodulation and the oral-gut microbiome axis: therapeutic potential and challenges Neda Hakimiha, Somayeh Jahani Sherafat, E-Liisa Laakso, Reza Fekrazad Frontiers in Medicine.2025;[Epub] CrossRef
Dinamiche del microbioma: dai cambiamenti nel corso della vita alla disbiosi nelle patologie tumorali Marcella NUNZIATO Biochimica Clinica.2025;[Epub] CrossRef
Gut microbiota — bidirectional modulator: role in inflammatory bowel disease and colorectal cancer Xilun Cui, Changfeng Li, Jing Zhong, Yuanda Liu, Pengtuo Xiao, Chang Liu, Mengwei Zhao, Wei Yang Frontiers in Immunology.2025;[Epub] CrossRef
Metabolic Disorders and Inflammatory Bowel Diseases Hye Kyung Hyun, Jae Hee Cheon Gut and Liver.2025; 19(3): 307. CrossRef
Incidence, Risk Factors, and Outcomes of Chronic Antibiotic-Refractory Pouchitis in Korean Patients with Ulcerative Colitis Ji Eun Baek, Jung-Bin Park, June Hwa Bae, Min Hyun Kim, Seung Wook Hong, Sung Wook Hwang, Jong Lyul Lee, Yong Sik Yoon, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Chang Sik Yu, Suk-Kyun Yang, Sang Hyoung Park Gut and Liver.2025; 19(3): 388. CrossRef
Personalized Microbiome Modulation to Improve Clinical Outcomes in Pediatric Inflammatory Bowel Disease: A Multi-Omics and Interventional Approach Adrian Goldiș, Radu Dragomir, Marina Adriana Mercioni, Christian Goldiș, Diana Sirca, Ileana Enătescu, Laura Olariu, Oana Belei Microorganisms.2025; 13(5): 1047. CrossRef
Engineering artificial microbial consortia for personalized gut microbiome modulation and disease treatment Timoth Mkilima Annals of the New York Academy of Sciences.2025; 1548(1): 29. CrossRef
Gastric Cancer and Microbiota: Exploring the Microbiome’s Role in Carcinogenesis and Treatment Strategies Daniela-Cornelia Lazăr, Sorin-Dan Chiriac, George-Andrei Drăghici, Elena-Alina Moacă, Alexandra Corina Faur, Mihaela-Flavia Avram, Vladiana-Romina Turi, Mihaela-Roxana Nicolin, Adrian Goldiș, Matin Asad Salehi, Radu Jipa Life.2025; 15(7): 999. CrossRef
TMAO and the gut microbiome: implications for the CVD-CKD-IBD axis Si Hyoung Kim, Mi Young Yoon, Sang Sun Yoon Annals of Medicine.2025;[Epub] CrossRef
Gut microbiota in non-alcoholic fatty liver disease: Pathophysiology, diagnosis, and therapeutics Himani Pandey, Prabudh Goel, Varunvenkat M Srinivasan, Daryl W T Tang, Sunny H Wong, Devi Lal World Journal of Hepatology.2025;[Epub] CrossRef
MH002, a Novel Butyrate-Producing Consortium of Six Commensal Bacterial Strains Has Immune-Modulatory and Mucosal-Healing Properties Iris Pinheiro, Selin Bolca, Lien Van den Bossche, Wiebe Vanhove, Sara Van Ryckeghem, Davide Gottardi, Debby Laukens, Sam Possemiers International Journal of Molecular Sciences.2025; 26(13): 6167. CrossRef
The Role of Probiotics, Prebiotics, Synbiotics, and Postbiotics in Livestock and Poultry Gut Health: A Review Taojing Yue, Yanan Lu, Wenli Ding, Bowen Xu, Cai Zhang, Lei Li, Fuchun Jian, Shucheng Huang Metabolites.2025; 15(7): 478. CrossRef
Ulcerative Colitis: Advances in Pathogenesis, Biomarkers, and Therapeutic Strategies Siyuan Bu, Xiaozhen Cheng, Meng Chen, Yongduo Yu Pharmacogenomics and Personalized Medicine.2025; Volume 18: 219. CrossRef
A study on gut microbiota and short-chain fatty acids in patients with inflammatory bowel disease from northwest Iran Samira Saedi, Safoura Derakhshan, Javid Sadeghi, Alka Hasani, Manouchehr Khoshbaten, Vahdat Poortahmasebi, Somayeh Ahmadi Letters in Applied Microbiology.2025;[Epub] CrossRef
Modulatory effects of synbiotic blend on selected human fecal bacteria and TNFα + LPS-induced inflammation in human intestinal epithelial cells Anita Rawat, Arka Bhattacharya, Rupa Tharu, Ruchika Maurya, Sanjay Kumar Bhadada, Mahendra Bishnoi, Kanthi Kiran Kondepudi The Microbe.2025; 8: 100512. CrossRef
Elderly-onset inflammatory bowel disease in Asia: clinical characteristics and therapeutic strategies Jiyoung Yoon, Daein Kim, You Sun Kim Intestinal Research.2025; 23(4): 430. CrossRef
Annexin A1 levels affect microbiota in health and DSS-induced colitis/inflammatory bowel disease development Luana Filippi Xavier, Ranko Gacesa, Gustavo Henrique Oliveira da Rocha, Milena Fronza Broering, Pablo Scharf, Fabiana da Silva Lima, Klaas Nico Faber, Hermie Harmsen, Christian Hoffmann, Sandra Helena Poliselli Farsky Frontiers in Immunology.2025;[Epub] CrossRef
The Effect of Cucumaria frondosa Tentacles Hydrolysates on Dextran Sulfate Sodium-Induced Colitis: Integrated Metagenomics and Metabolomics Analysis Senyu Zhang, Qiuting Wang, Shunmin Gong, Mingbo Li, Yu Zhang, Leilei Sun, Liqin Sun Foods.2025; 14(20): 3483. CrossRef
The gut immune axis in ulcerative colitis: insights from microbiome research Rufaida Wasim Molecular Biology Reports.2025;[Epub] CrossRef
Integrating gut microbiota and metabolomics in pediatric inflammatory bowel disease: insights into pathogenesis and potential role of precision medicine Rui Dong, Xiaoling Meng, Haiyan Hu, Jie Pan, Wei Wang European Journal of Medical Research.2025;[Epub] CrossRef
Immunocyte lipid metabolic reprogramming: a novel pathway for targeted intervention in autoimmune diseases Yanyu Cui, Zhendong Feng, Qihan Zhao, Haoran Dai, Yang Zheng, Hongliang Rui, Baoli Liu Frontiers in Immunology.2025;[Epub] CrossRef
Natural polyphenols in ulcerative colitis: preclinical mechanisms of action and therapeutic potential Chengu Niu, Jing Zhang, Patrick I. Okolo International Journal of Food Sciences and Nutrition.2025; 76(8): 825. CrossRef
The gut microbiota and its metabolites: novel therapeutic targets for inflammatory bowel disease Xingyu Shen, Yue Li, Deqiang Wang, Kang Sun Frontiers in Immunology.2025;[Epub] CrossRef
Th17/Treg imbalance in inflammatory bowel disease: immunological mechanisms and microbiota-driven regulation Yuyuan Hu, Yuhang Yang, Yan Li, Qiang Zhang, Wei Zhang, Jinghan Jia, Zhuoyi Han, Jinxi Wang Frontiers in Immunology.2025;[Epub] CrossRef
Integrated Multi-Omics Analysis Identifies Novel Prognostic and Diagnostic Hub Genes in Colorectal Cancer Devi Lal, Himani Pandey Onco.2025; 5(4): 50. CrossRef
Comparative insights into gut microbiota, diet, and inflammation in Inflammatory Bowel Diseases and canine enteropathy Miljana Glazar, Sonia Facchin Academia Nutrition and Dietetics.2025;[Epub] CrossRef
Editorial: Environments-pathogens-the gut microbiota and host diseases Jinbo Xiong, Zunji Shi Frontiers in Microbiology.2024;[Epub] CrossRef
Endoplasmic reticulum stress: A possible connection between intestinal inflammation and neurodegenerative disorders Giorgio Vivacqua, Romina Mancinelli, Stefano Leone, Rosa Vaccaro, Ludovica Garro, Simone Carotti, Ludovica Ceci, Paolo Onori, Luigi Pannarale, Antonio Franchitto, Eugenio Gaudio, Arianna Casini Neurogastroenterology & Motility.2024;[Epub] CrossRef
Advances in Precision Medicine Approaches for Colorectal Cancer: From Molecular Profiling to Targeted Therapies Neelakanta Sarvashiva Kiran, Chandrashekar Yashaswini, Rahul Maheshwari, Sankha Bhattacharya, Bhupendra G. Prajapati ACS Pharmacology & Translational Science.2024; 7(4): 967. CrossRef
Healing from Within: How Gut Microbiota Predicts IBD Treatment Success—A Systematic Review Luana Alexandrescu, Alina Doina Nicoara, Doina Ecaterina Tofolean, Alexandra Herlo, Andreea Nelson Twakor, Cristina Tocia, Anamaria Trandafir, Andrei Dumitru, Eugen Dumitru, Cristian Florentin Aftenie, Ionela Preotesoiu, Elena Dina, Ioan Tiberiu Tofolean International Journal of Molecular Sciences.2024; 25(15): 8451. CrossRef
Effect of Mutant and Engineered High-Acetate-Producing Saccharomyces cerevisiae var. boulardii Strains in Dextran Sodium Sulphate-Induced Colitis Sara Deleu, Inge Jacobs, Jorge F. Vazquez Castellanos, Sare Verstockt, Bruna Trindade de Carvalho, Ana Subotić, Bram Verstockt, Kaline Arnauts, Lowie Deprez, Eva Vissers, Matthias Lenfant, Greet Vandermeulen, Gert De Hertogh, Kristin Verbeke, Gianluca Mat Nutrients.2024; 16(16): 2668. CrossRef
The emerging role of the gut microbiota and its application in inflammatory bowel disease Xiu Wang, Jianhua Peng, Peipei Cai, Yuxuan Xia, Chengxue Yi, Anquan Shang, Francis Atim Akanyibah, Fei Mao Biomedicine & Pharmacotherapy.2024; 179: 117302. CrossRef
Bifidogenic Effect of Human Milk Oligosaccharides on Pediatric IBD Fecal Microbiota Nize Otaru, Danica Bajic, Pieter Van den Abbeele, Saskia Vande Velde, Stephanie Van Biervliet, Robert E. Steinert, Ateequr Rehman Microorganisms.2024; 12(10): 1977. CrossRef
Analysis of the Preventive Effect of Lonicera caerulea Pomace and Its Isolated Components on Colitis in Mice Based on Gut Microbiota and Serum Metabolomics Zinuo Zhou, Xinwen Huang, Baixi Zhang Antioxidants.2024; 13(12): 1478. CrossRef
Gut microbiota mediated T cells regulation and autoimmune diseases Nabeel Khalid Bhutta, Xiujin Xu, Cuiqin Jian, Yifan Wang, Yi Liu, Jinlyu Sun, Bingnan Han, Shandong Wu, Ansar Javeed Frontiers in Microbiology.2024;[Epub] CrossRef
Reduced gut microbiota diversity in ulcerative colitis patients with latent tuberculosis infection during vedolizumab therapy: insights on prophylactic anti-tuberculosis effects Yibing Hu, Zhenping Wu, Xiaoyun Yang, Jin Ding, Qunying Wang, Hao Fang, Lujian Zhu, Minli Hu BMC Microbiology.2024;[Epub] CrossRef